Sciety becomes a member in the trade association SwedenBIO that works for a strong life science sector in Sweden. The members include micro companies to big pharma but also companies that provide services in business development, IP, financing and etc. As Sciety works with financing of unlisted companies, in the
The new issue of shares in EMPE Diagnostics was fully subscribed already two weeks before the subscription period expired. EMPE Diagnostics develops a rapid test for diagnosis of tuberculosis. In total, 10 million SEK was invested and the funding will be used for final product validation and market launch.
Last week, the trade associations LIF, Swedish Medtech and SwedenBIO presented an action plan to strengthen the competitiveness of Swedish life science. As Sciety meets many companies that develop the healthcare sector, we find it is very interesting that one of the three topics in the plan is to introduce
Sciety closes a financing round of 10 million SEK and welcomes thirty new shareholders with backgrounds in the finance and healthcare sectors. The largest investor is the investment company Linc. Sciety is an investment platform focusing on unlisted growth companies in the healthcare sector. Since Sciety’s launch during the autumn
One week ago, the medical technology company Attana that previously raised funding via Sciety listed its shares on the NGM stock exchange. The company has developed technology to improve efficiency in the development of new drugs and is the second company financed by Sciety to be listed. Sciety
Ett trettiotal affärsänglar går in med 20 miljoner kronor i diagnostikbolaget som med sin innovativa mjukvara ska bekämpa det globala hotet från antibiotikaresistens. Investeringarna sker via Sciety som är specialiserat på tillväxtbolag inom hälsa och medicin. Med 1928 Diagnostics mjukvara kan man med hjälp av teknik som redan finns på